deltatrials
Completed NA NCT00986921

Mifepristone Versus Laminaria Insertion for Cervical Preparation Prior to Surgical Abortion at 14-16 Weeks

Mifepristone vs. Laminaria Insertion for Cervical Preparation Prior to Surgical Abortion at 14-16 Weeks

Sponsor: Boston University

Conditions Abortion
Interventions mifepristone 200 mg osmotic dilator insertion
Updated 7 times since 2017 Last updated: Dec 28, 2013 Started: Oct 31, 2009 Primary completion: Mar 31, 2011 Completion: Mar 31, 2011

Listed as NCT00986921, this NA trial focuses on Abortion and remains completed. Sponsored by Boston University, it has been updated 7 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Dec 2021 — Jul 2024 [monthly]

    Completed NA

  4. Jan 2021 — Dec 2021 [monthly]

    Completed NA

  5. Jun 2018 — Jan 2021 [monthly]

    Completed NA

▶ Show 2 earlier versions

  1. Feb 2017 — Jun 2018 [monthly]

    Completed NA

  2. Jan 2017 — Feb 2017 [monthly]

    Completed NA

    First recorded

Oct 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Boston University
  • Society of Family Planning
Data source: Boston University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Boston, United States